These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36194039)

  • 1. TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma.
    Lima HA; Endo Y; Moazzam Z; Alaimo L; Shaikh C; Munir MM; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Endo I; Kitago M; Shen F; Pawlik TM
    J Surg Oncol; 2023 Mar; 127(3):374-384. PubMed ID: 36194039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma.
    Lima HA; Endo Y; Alaimo L; Moazzam Z; Munir MM; Shaikh C; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Kitago M; Shen F; Pawlik TM
    J Gastrointest Surg; 2022 Dec; 26(12):2512-2521. PubMed ID: 36171471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIVKA-II combined with tumor burden score to predict long-term outcomes of AFP-negative hepatocellular carcinoma patients after liver resection.
    Qiu ZC; Wu YW; Qi WL; Li C
    Cancer Med; 2024 Jan; 13(1):e6835. PubMed ID: 38130028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.
    Tsilimigras DI; Moris D; Hyer JM; Bagante F; Sahara K; Moro A; Paredes AZ; Mehta R; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Sasaki K; Rodarte AI; Aucejo FN; Pawlik TM
    Br J Surg; 2020 Jun; 107(7):854-864. PubMed ID: 32057105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection.
    Qiu ZC; Li C; Zhang Y; Xie F; Yu Y; Leng SS; Chen TH; Wen TF
    Langenbecks Arch Surg; 2023 Jun; 408(1):250. PubMed ID: 37382724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of tumor recurrence by α-fetoprotein model after curative resection for hepatocellular carcinoma.
    Ding HF; Zhang XF; Bagante F; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Lv Y; Pawlik TM
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):660-666. PubMed ID: 33082065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
    Tsilimigras DI; Mehta R; Moris D; Sahara K; Bagante F; Paredes AZ; Farooq A; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Mar; 27(3):866-874. PubMed ID: 31696396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
    Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
    Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preoperative model to predict overall survival in patients with hepatoma undergoing resection.
    Li WF; Moi SH; Liu YW; Lin CC; Yong CC; Wang CC; Yen YH; Lin CY
    Am J Surg; 2024 Nov; 237():115778. PubMed ID: 38811240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
    Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
    Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
    Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
    World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiographic tumor burden score is useful for stratifying the overall survival of hepatocellular carcinoma patients undergoing resection at different Barcelona Clinic Liver Cancer stages.
    Li WF; Liu YW; Wang CC; Yong CC; Lin CC; Yen YH
    Langenbecks Arch Surg; 2023 May; 408(1):169. PubMed ID: 37121930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma.
    Li WF; Yen YH; Liu YW; Wang CC; Yong CC; Lin CC; Cheng YF; Wang JH
    Updates Surg; 2022 Aug; 74(4):1345-1352. PubMed ID: 34374920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.
    Lima HA; Moazzam Z; Endo Y; Alaimo L; Shaikh C; Munir MM; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Kitago M; Shen F; Pawlik TM
    Ann Surg Oncol; 2023 Jun; 30(6):3363-3373. PubMed ID: 36820934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.
    Wei H; Fu F; Jiang H; Wu Y; Qin Y; Wei H; Yang T; Wang M; Song B
    Eur Radiol; 2023 Nov; 33(11):7631-7645. PubMed ID: 37191923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria.
    Tsilimigras DI; Bagante F; Moris D; Hyer JM; Sahara K; Paredes AZ; Mehta R; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Jul; 27(7):2321-2331. PubMed ID: 32285278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma.
    Lima HA; Alaimo L; Brown ZJ; Endo Y; Moazzam Z; Tsilimigras DI; Shaikh C; Resende V; Guglielmi A; Ratti F; Aldrighetti L; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Shen F; Pawlik TM
    HPB (Oxford); 2023 Feb; 25(2):260-268. PubMed ID: 36470717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoprotein.
    Santambrogio R; Opocher E; Costa M; Barabino M; Zuin M; Bertolini E; De Filippi F; Bruno S
    Ann Surg Oncol; 2012 Feb; 19(2):426-34. PubMed ID: 21732145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
    Gómez-Rodríguez R; Romero-Gutiérrez M; Artaza-Varasa T; González-Frutos C; Ciampi-Dopazo JJ; de-la-Cruz-Pérez G; Sánchez-Ruano JJ
    Rev Esp Enferm Dig; 2012 Jun; 104(6):298-304. PubMed ID: 22738699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.